CNBX — CNBX Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Cannabics Prepares To Submit FDA With Pre-IND Meeting Request For Proprietary Colon Cancer Drug Candidate
Brief: Cannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor To Its Scientific Board Of Advisors
Brief: Cannabics Pharmaceuticals Initiates Entry For Its Cannabinoid Diagnostic Platform Into European Markets
Brief: Cannabics Pharmaceuticals & Cannomed Collaborate To Develop Cannabis Strains Targeting Cancers
Brief: Cannabics Pharmaceuticals Announces Publication Of Clinical Data From Pilot Study
White House may boost recreational marijuana enforcement -spokesman (updated)